Subveho

we provide venture capital groups, angel investors, academic-affiliated institutions, and other early stage pharmaceutical investors an experienced and innovative team to drive focused, efficient translational development of pharmaceutical assets. subveho provides the management team to drive the asset through value inflection points, broaden the network of potential partners and investors, and progress the program to its business and scientific goals. by de-centralizing the management team from individual assets, subveho offers investors the opportunity to progress assets efficiently, without having to shoulder the full overhead of a company for a single early stage asset while still retaining the benefits of an established company. subveho provides a stable team of experts, experienced in working together in the start-up space, whose incentives are aligned with the investors and founders.